Professional Documents
Culture Documents
The Artificial Pancreas How Will This Benefit Patiens With DIabetes
The Artificial Pancreas How Will This Benefit Patiens With DIabetes
The Artificial Pancreas How Will This Benefit Patiens With DIabetes
In type 1 diabetes, the pancreas cannot produce insulin, which is why the body cannot
naturally control blood sugar itself. In the absence of adequate treatment, the disease can
lead to extremely serious complications: loss of vision, renal failure, cardiovascular disease.
The artificial pancreas is a technology that has been developing since the 1970s, which is
intended to be a solution against type 1 diabetes. The pancreatic implant is a medical device
that should be placed inside the abdomen. It is also called ‘bio-artificial’ pancreas:
artificially, because it is made of a synthetic polymeric material and bio, because it
complements a biological function, that of the pancreas. Type 1 diabetes is a disease that
triggers when the pancreas decreases insulin secretion until it is almost completely absent,
with increased blood glucose. The incidence of this disease has increased significantly over
the last decades due to (in particular) changes in environmental factors and (less) genetic
factors (which require much more time to change within the human species).
The patient using this medical device, the artificial pancreas, also called closed-loop insulin
delivery system, will have a normal life span without taking care of glycaemic control and
regular insulin administration. He just has to calibrate the device periodically twice a day by
measuring glucose and enter the carbohydrate information he will consume at each meal.
Next, the device will calculate and administer the correct insulin dose on its own to keep the
glucose level within normal limits.
The artificial pancreas promises a chance for a normal life for type 1 diabetes patients who
are currently forced to inject insulin. Another advantage of the artificial pancreas is that the
blood glucose level is always kept under observation, so the risks to which the patient is
exposed diminishes. The automatic procedure eliminates the risk of forgetting taking the
insulin dose. Also, the patient can take carbohydrates if the device noticed that the glucose
level falls below normal, thus avoiding a possible complication.
The artificial pancreas promises an innovative solution for type 1 diabetes and has many
advantages. however, it is not a perfect system and it also comes with disadvantages. It is
quite uncomfortable, requiring two permanent devices that may have technical problems.
The skin can become irritated from the devices, athletes are prevented from performing at
the performance level. Another disadvantage is that Continuous Glucose Monitor checks
the glucose level in the interstitial fluid that does not change values as fast as the blood
glucose level, and so the result displayed by the Continuous Glucose Monitor may be
erroneous.
Diabetes mellitus is not a new "disease" but has been known for millennia, and its clinical
manifestations have been described since antiquity in Ebers Papyrus - 1500 BC. Nowadays,
questions like: Why did my diabetes develop? Who is to blame? What should I do to prevent
diabetes? remain unanswered, still remain unanswered, great hopes to solve this problem
are the artificial pancreas. The progress made in this area since the 1970s has been
remarkable, the benefits of this automatic insulin delivery system overcoming the
disadvantages presented above.
References:
1. Graham K. & Dean S. (2018) Fundamentals of anatomy & physiology, Pearson press
2. Subrata P. (2014) Design of Artificial Human Joints & Organs, Springer Press
4. The artificial pancreas in 2017: The year of transition from research to clinical
practice (2017) [online] available at:
https://www.nature.com/search?q=artificial%20pancreas%20&order=relevance
5. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review
and meta-analysis (2018) [online] available at:
https://www.bmj.com/content/361/bmj.k1310